ChristopherJeffrey CharlesRodgmanMDFASAM

Addiction

Physician

Dr. Rodgman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Alexandria Solutions
5920 Coliseum Blvd
Alexandria, LA 71303
Phone+1 318-443-9339

Fax+1 318-442-2261

Dr. Christopher Rodgman is a psychiatrist specializing in addiction, based in Alexandria, LA. He completed his residency in psychiatry at Tulane University in 2012 and graduated from Ross University School of Medicine in 2009. Dr. Rodgman currently practices at Alexandria Solutions. His research contributions include publications on the effects of THC on working memory, detoxification from synthetic cannabinoids, Internet-based self-diagnosis of "Morgellon's disease," opioid dependence related to cardiac transplantation, and the acute psychosis associated with marijuana substitutes. His work has been cited multiple times in other scientific literature.

PubMed

3 citations
Use of Guanfacine for Cannabis Use Disorder and Related Symptomology.
Manuela Holst, David S. Mathai, Marguerite M. Patel, Christopher Rodgman, Jake Keller
The American Journal on Addictions. 2019-11-01
Use of Guanfacine for Cannabis use Disorder and Related Symptomology.
Manuela Holst, David S Mathai, Marguerite M Patel, Christopher Rodgman, Jake Keller
The American journal on addictions. 2019-09-05
7 citations
Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study.
David S. Mathai, Manuela Holst, Christopher Rodgman, Colin N. Haile, Jake Keller
The Journal of Neuropsychiatry and Clinical Neurosciences. 2017-06-23